Colonial Trust Advisors’s Elevance Health ELV Stock Holding History

Colonial Trust Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$58.5K	Sell	200 -69	-26%	-$22.7K	﹤0.01%	332
2025 Q4	$94.3K	Hold	269	–	–	0.01%	273
2025 Q3	$86.9K	Hold	269	–	–	0.01%	277
2025 Q2	$105K	Hold	269	–	–	0.01%	257
2025 Q1	$117K	Hold	269	–	–	0.01%	249
2024 Q4	$99.2K	Hold	269	–	–	0.01%	244
2024 Q3	$140K	Hold	269	–	–	0.01%	228
2024 Q2	$146K	Sell	269 -3	-1%	-$1.59K	0.01%	207
2024 Q1	$141K	Sell	272 -9	-3%	-$4.48K	0.01%	210
2023 Q4	$133K	Sell	281 -150	-35%	-$69.4K	0.01%	211
2023 Q3	$188K	Hold	431	–	–	0.02%	188
2023 Q2	$191K	Sell	431 -1	-0.2%	-$461	0.02%	194
2023 Q1	$199K	Sell	432 -1	-0.2%	-$476	0.02%	189
2022 Q4	$222K	Buy	433 +169	+64%	+$85.8K	0.03%	193
2022 Q3	$120K	Buy	+264	New	+$126K	0.02%	208

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Colonial Trust Advisors's ELV Position: Q1 2026 in Review

Colonial Trust Advisors reduced its Elevance Health (ELV) stake by 26% in Q1 2026, selling an estimated $22.7K and leaving 200 shares worth $58.5K. The position accounts for ﹤0.01% of the portfolio, ranked #332.

Colonial Trust Advisors first reported a position in ELV in Q3 2022 and has held it in 15 quarters since. The position peaked at $222K in Q4 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Colonial Trust Advisors held 200 shares of Elevance Health worth $58.5K as of Q1 2026.
Colonial Trust Advisors sold 69 Elevance Health shares in Q1 2026, an estimated $22.7K.
Elevance Health made up ﹤0.01% of Colonial Trust Advisors's portfolio in Q1 2026, its #332 holding.
Colonial Trust Advisors first reported a position in Elevance Health in Q3 2022 and has held it in 15 quarters since.
Colonial Trust Advisors's Elevance Health position peaked at $222K in Q4 2022.
1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Colonial Trust Advisors's 13F filing for Q1 2026, filed 12 May 2026.